Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eszopiclone 3 mg vs placebo: next-day driving and psychomotor/memory function in primary insomnia
2004-000235-28Phase 3Completed
- Sponsor
- Sunovion
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in chronic insomnia comparing Eszopiclone 3 mg with Placebo (2 arms). Primary endpoint: Mean brake reaction time following illumination of red lamp. Started Feb 2005; status: completed.
02
Drugs
eszopiclone
03
Conditions
chronic insomnia
Beyond the preview
Go deeper on 2004-000235-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000235-28.